These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25194454)

  • 21. Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
    Stokkel MP; Dibbets-Schneider P; Koestering E; Dragoiescu C; Blokland KA
    J Nucl Med Technol; 2007 Mar; 35(1):21-6. PubMed ID: 17337653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.
    Gaenslen A; Unmuth B; Godau J; Liepelt I; Di Santo A; Schweitzer KJ; Gasser T; Machulla HJ; Reimold M; Marek K; Berg D
    Lancet Neurol; 2008 May; 7(5):417-24. PubMed ID: 18394965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
    Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
    Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.
    Vlaar AM; de Nijs T; van Kroonenburgh MJ; Mess WH; Winogrodzka A; Tromp SC; Weber WE
    BMC Neurol; 2008 Nov; 8():42. PubMed ID: 18992168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.
    Heim B; Peball M; Hammermeister J; Djamshidian A; Krismer F; Seppi K
    J Parkinsons Dis; 2022; 12(4):1115-1123. PubMed ID: 35180133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter Semiquantitative Evaluation of (123)I-FP-CIT Brain SPECT.
    Skanjeti A; Castellano G; Elia BO; Zotta M; Dazzara F; Manfredi M; Galati A; Grimaldi S; Balma M; Pellerito RE; Podio V
    J Neuroimaging; 2015; 25(6):1023-9. PubMed ID: 25923060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.
    Unger MM; Möller JC; Stiasny-Kolster K; Mankel K; Berg D; Walter U; Hoeffken H; Mayer G; Oertel WH
    Mov Disord; 2008 Mar; 23(4):596-9. PubMed ID: 18175346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study.
    Bajaj NP; Gontu V; Birchall J; Patterson J; Grosset DG; Lees AJ
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1223-8. PubMed ID: 20547625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of the substantia nigra echogenicity and
    Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
    Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with
    Bae YJ; Kim JM; Kim KJ; Kim E; Park HS; Kang SY; Yoon IY; Lee JY; Jeon B; Kim SE
    Radiology; 2018 Apr; 287(1):285-293. PubMed ID: 29232183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcranial Brain Sonography in Parkinson's Disease and Other Parkinsonian Disorders: a Hospital Study from Tuzla, Bosnia and Herzegovina.
    Smajlovic D; Ibrahimagic OC
    Med Arch; 2017 Aug; 71(4):261-264. PubMed ID: 28974846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.
    Bajaj N; Hauser RA; Grachev ID
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1288-95. PubMed ID: 23486993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transcranial sonography (TCS) in evaluation of patients with essential tremor].
    Budisić M; Trkanjec Z; Lovrencić-Huzjan A; Supanc V; Vuković V; Demarin V
    Acta Med Croatica; 2009 Dec; 63 Suppl 3():51-4. PubMed ID: 20232670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of an automated morphological MRI-based (123)I-FP-CIT SPECT evaluation method.
    Perlaki G; Szekeres S; Orsi G; Papp L; Suha B; Nagy SA; Doczi T; Janszky J; Zambo K; Kovacs N
    Parkinsonism Relat Disord; 2016 Aug; 29():24-9. PubMed ID: 27290659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
    Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
    J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of the combined use of
    Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
    Acta Radiol; 2019 Feb; 60(2):230-238. PubMed ID: 29804474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.